title: Potential and Caveats of Lipidomics for Cardiovascular Disease.
authors.affiliation: From Department of Neurology, Medical University of Innsbruck, Austria (R.P., S.K.); and King's British Heart Foundation Centre, King's College London, United Kingdom (M.M.).
authors.forename: Raimund
authors.initials: R
authors.lastname: Pechlaner
authors.affiliation: From Department of Neurology, Medical University of Innsbruck, Austria (R.P., S.K.); and King's British Heart Foundation Centre, King's College London, United Kingdom (M.M.).
authors.forename: Stefan
authors.initials: S
authors.lastname: Kiechl
authors.affiliation: From Department of Neurology, Medical University of Innsbruck, Austria (R.P., S.K.); and King's British Heart Foundation Centre, King's College London, United Kingdom (M.M.). manuel.mayr@kcl.ac.uk.
authors.forename: Manuel
authors.initials: M
authors.lastname: Mayr
mesh_terms: D002318:Cardiovascular Diseases; D006801:Humans; D050356:Lipid Metabolism; D008055:Lipids; D055432:Metabolomics
chemical_list: D008055:Lipids
keywords: atherosclerosis; biomarkers; coronary artery disease; lipids; mass spectrometry